Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes.
Date
2016-01
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Invasive cervical cancer disproportionately affects women without sufficient access to care, with higher rates among minority groups in higher-income countries and women in low-resource regions of the world. Many elements contribute to racial/ethnic disparities in the cervical cancer continuum - from screening and diagnosis to treatment and outcome. Sociodemographic factors, access to healthcare, income and education level, and disease stage at diagnosis are closely linked to such inequities. Despite the identification of such elements, racial/ethnic disparities persist, and are widening in several minority subgroups, particularly in older women, who are ineligible for human papillomavirus (HPV) vaccination and are underscreened. Recent studies suggest that racial/ethnic differences in HPV infection exist and may also have a role in observed differences in cervical cancer. In this review, we provide an overview of the current literature on racial disparities in cervical cancer screening, incidence, treatment and outcome to inform future strategies to reduce persistent inequities.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Musselwhite, Laura W, Cristina M Oliveira, Tendai Kwaramba, Naitielle de Paula Pantano, Jennifer S Smith, José Humberto Fregnani, Rui M Reis, Edmundo Mauad, et al. (2016). Racial/Ethnic Disparities in Cervical Cancer Screening and Outcomes. Acta cytologica, 60(6). pp. 518–526. 10.1159/000452240 Retrieved from https://hdl.handle.net/10161/33513.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Tendai Kwaramba
Dr. Tendai Kwaramba is a physician-researcher and medical oncologist specializing in gastrointestinal malignancies and global oncology. Her research centers on improving equitable access to cancer prevention, diagnosis, treatment, and survivorship care in resource-limited settings. She leads an ASCO-Conquer Cancer Young Investigator Award–funded study evaluating the implementation of evidence-based treatment de-escalation strategies for early breast cancer in South Africa. Her work bridges health equity, implementation science, and clinical oncology, with a particular focus on optimizing care delivery and resource utilization in low- and middle-income countries.
At Duke Cancer Institute, Dr. Kwaramba is developing research infrastructure that links cancer registry and precision medicine capacity in East Africa. Her broader scholarly portfolio includes work on cancer survivorship risk modeling, early onset cancers, community engagement, disparities in palliative care delivery, and the inclusion of underrepresented populations in cancer research. Drawing on her multidisciplinary background in global health and oncology, Dr. Kwaramba aims to lead collaborative, data-driven initiatives that reduce disparities and advance equitable cancer outcomes worldwide.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.